Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Mark W. Stolar"'
Publikováno v:
Cureus
Latent autoimmune diabetes in adults (LADA) is a type of slow-onset, immune-mediated insulin deficiency involving progressive destruction of beta-cell function. Despite sharing some similarities with both type 1 and type 2 diabetes, LADA is a separat
Publikováno v:
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Exenatide once weekly (EQW), the first glucose-lowering agent for type 2 diabetes that is dosed one time per week, contains exenatide encapsulated in microspheres of a dissolvable matrix, which release active agent slowly and continuously into the ci
Autor:
Mark W. Stolar
Publikováno v:
The American Journal of Medicine. 123:S3-S11
Current guidelines for treating patients with type 2 diabetes mellitus are based on glycemic standards derived from epidemiologic data; however, the course of the disease, from prediabetes to end-stage complications, is not the same in all patients.
Publikováno v:
Postgraduate Medicine. 120:002-012
Publikováno v:
Journal of Managed Care Pharmacy. 14:1-22
BACKGROUND: Aggressive management of type 2 diabetes is necessary to achieve glycemic and nonglycemic treatment goals. Attainment oftreatment goals is associated with a decreased risk of diabetes-r...
Autor:
Mark W. Stolar
Publikováno v:
Cleveland Clinic Journal of Medicine. 74:199-202
The metabolic syndrome--the cluster of obesity, impaired fasting glucose, elevated triglycerides, low high-density lipoprotein cholesterol, and hypertension--may not be a "real" syndrome in the strict sense. It can, however, still be a useful concept
Autor:
Robert J. Chilton, Mark W. Stolar
Publikováno v:
Clinical Therapeutics. 25:B4-B31
Background: Patients with type 2 diabetes mellitus frequently have coexistent dyslipidemia, hypertension, and obesity, and are at risk for microvascular and macrovascular disease complications such as myocardial infarction, stroke, retinopathy, and m
Autor:
Mark W. Stolar
Publikováno v:
American Journal of Health-System Pharmacy. 59:S3-S8
The etiology, natural history, and relationship of insulin resistance to type 2 diabetes mellitus and the effects of insulin-sensitizing agents are described. Insulin resistance results from a combination of genetic and environmental factors and cont
Autor:
Moisés Mercado, Tauhid Jan, Norma Davila, Melissa M. Shaw, MacCart John, Mark W. Stolar, Klauss Amburn, Gerhard Baumann
Publikováno v:
Nuclear Medicine and Biology. 21:369-379
Human growth hormone (GH) represents a family of related proteins arising from two genes, alternative mRNA splicing, and several post-translational modifications. In addition, postsecretory events occur when GH enters the circulation. The full scale
Autor:
Mark W. Stolar
Traditionally, successful treatment of patients with type 2 diabetes mellitus (DM) has been defined strictly by achievement of targeted glycemic control, primarily using a stepped-care approach that begins with changes in lifestyle combined with oral
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15470558897c02a2f256a46deaa071cd
https://europepmc.org/articles/PMC2996162/
https://europepmc.org/articles/PMC2996162/